News Releases

Date	Title
04/03/2023	Heron Therapeutics Announces New CEO and Board Chairman
03/23/2023	Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Highlights Recent Corporate Updates
03/13/2023	Heron Therapeutics Announces Centers for Medicare & Medicaid Services (CMS) Granted Pass-through Payment Status for APONVIE™, Effective April 1, 2023
03/10/2023	Heron Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 23, 2023
03/06/2023	Heron Therapeutics Announces U.S. Commercial Launch of APONVIE™ for the Management of Postoperative Nausea and Vomiting in Adults
02/27/2023	Heron Therapeutics Announces Presentation at 43rd Annual Cowen Healthcare Conference
02/22/2023	Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital
01/09/2023	Heron Therapeutics Highlights Progress in Acute Care and Oncology Care Franchises

Keyword Search